3-(pyridin-3-yl)acryloyl chloride hydrochloride | 3272-03-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 3-(pyridin-3-yl)acryloyl chloride hydrochloride
• 英文别名: 3-(3-Pyridyl)acryloyl chloride hydrochloride；3-pyridin-3-ylprop-2-enoyl chloride;hydrochloride
• CAS: 3272-03-5
• 化学式: C₈H₆ClNO*ClH
• 分子量: 204.056
• InChiKey: PVASFTAFYFDJDA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.28
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  30
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-(pyridin-3-yl)acryloyl chloride hydrochloride 在 盐酸 、 三乙胺 作用下， 以 乙醇 、 二氯甲烷 为溶剂， 反应 73.0h， 生成 7,7-dimethyl-2-(2-pyridin-3-ylethenyl)-1,5-dihydropyrrolo[2,3-f]benzimidazol-6-one
  参考文献：
  名称：

  Nonsteroidal cardiotonics. 1. 2-Pyridyl-6,7-dihydro-3H,5H-pyrrolo[2,3-f]benzimidazol-6-ones, a novel class of cardiotonic agents

  摘要：

  A series of substituted 2-pyridyl-6,7-dihydro-3H,5H-pyrrolo[2,3-f]benzimidazol-6-ones 1-24 were synthesized and evaluated for positive inotropic activity. In rats, cats, and dogs most of these tricyclic heterocycles produced a dose-related increase in myocardial contractility with little effect on heart rate and blood pressure. The increase in contractility was not mediated via stimulation of beta-adrenergic receptors. Compound 1 (BM 14.478) was more potent than milrinone (25) and enoximone when administered intravenously to rats, cats, and dogs. After oral administration of 1 mg/kg, compound 1, milrinone, and pimobendan were equipotent. However, only 1 and pimobendan were still active after 6 h. The structural requirements necessary for optimal cardiotonic activity within this novel class of heterocycles were investigated.

  DOI：

  10.1021/jm00391a004
• 作为产物：
  描述：

  3-(3-吡啶)丙烯酸 在 N,N-二甲基甲酰胺 草酰氯 作用下， 以 二氯甲烷 为溶剂， 反应 3.5h， 以87%的产率得到3-(pyridin-3-yl)acryloyl chloride hydrochloride
  参考文献：
  名称：

  [EN] NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT
  [FR] NOUVEAUX COMPOSÉS ET COMPOSITIONS UTILISÉS DANS L'INHIBITION DE NAMPT

  摘要：

  本发明涉及用于抑制NAMPT的化合物和组合物，其合成、应用和解毒剂。该发明的一个示例化合物如下所示。

  公开号：

  WO2012150952A1

文献信息

• Separation agent comprising acyl- or carbamoyl-substituted polysaccharide
  申请人：Daicel Chemical Industries, Ltd.

  公开号：US05415780A1

  公开（公告）日：1995-05-16

  Separation of a chemical substance is effected by treating a mixture thereof with a polysaccharide having a substituent for hydroxyl group an acyl group of the formula (1) or a carbamoyl group of the formula (2): ##STR1## wherein R represents an atomic group having a nucleus comprising a conjugated .pi.-bond system in which the number of bonds interposed between an atom contained therein and bonded with the carbonyl or amino group and an atom contained in the .pi.-bond system and most distant from said atom is at least 5 even in the shortest route.

  一种化学物质的分离是通过使用具有羟基取代基的多糖或具有以下式（1）的酰基基团或以下式（2）的氨基甲酰基团的多糖处理其混合物来实现的：其中R表示具有核含有共轭π-键系统的原子团，其中包含在其中并与羰基或氨基团结合并且距离最远的π-键系统中的原子之间插入的键的数量至少为5，即使在最短路径中也是如此。
• Separation agent comprising acyl-or carbamoyl-substituted polysaccharide
  申请人：Daicel Chemical Industries, Ltd.

  公开号：US05368737A1

  公开（公告）日：1994-11-29

  Separation of a chemical substance is effected by treating a mixture thereof with a polysaccharide having a substituent for hydroxyl group an acyl group of the formula (1) or a carbamoyl group of the formula (2): ##STR1## wherein R represents an atomic group having a nucleus comprising a conjugated .pi.-bond system in which the number of bonds interposed between an atom contained therein and bonded with the carbonyl or amino group and an atom contained in the .pi.-bond system and most distant from said atom is at least 5 even in the shortest route.

  一种化学物质的分离是通过使用具有取代羟基的多糖，其酰基的公式为（1）或者羰基的公式为（2）来处理其混合物实现的：##STR1## 其中R代表具有包含一个共轭的π-键系统的核的原子团，在其中包含在π-键系统中并且距离该原子最远的原子之间插入的键的数量至少为5，即使在最短路径中也是如此。
• Acrylamide Derivative And Use Thereof In Manufacture Of Medicament
  申请人：Sun Shuping

  公开号：US20120116075A1

  公开（公告）日：2012-05-10

  An acrylamide derivative represented by formula (I), pharmaceutically acceptable salts and solvates thereof, as well as a medicament containing said acrylamide derivative or its pharmaceutically acceptable salts as the active ingredient, which can be used to treat disorders associated with tyrosine kinase especially Bcr-Abl, including proliferative disorders such as cancers, and inflammation and the like are provided.

  提供一种由式（I）表示的丙烯酰胺衍生物，其药学上可接受的盐和溶剂化物，以及包含该丙烯酰胺衍生物或其药学上可接受的盐作为活性成分的药物，可用于治疗与酪氨酸激酶特别是Bcr-Abl相关的疾病，包括增殖性疾病如癌症，以及炎症等。
• Acrylamide derivative and use thereof in manufacture of medicament
  申请人：Sun Shuping

  公开号：US08426446B2

  公开（公告）日：2013-04-23

  An acrylamide derivative represented by formula (I), pharmaceutically acceptable salts and solvates thereof, as well as a medicament containing said acrylamide derivative or its pharmaceutically acceptable salts as the active ingredient, which can be used to treat disorders associated with tyrosine kinase especially Bcr-Abl, including proliferative disorders such as cancers, and inflammation and the like are provided.

  提供一种由公式（I）表示的丙烯酰胺衍生物，其药学上可接受的盐和溶剂化合物，以及包含该丙烯酰胺衍生物或其药学上可接受的盐作为活性成分的药物，可用于治疗与酪氨酸激酶特别是Bcr-Abl相关的紊乱，包括增殖性紊乱如癌症和炎症等。
• Compounds and compositions for the inhibition of NAMPT
  申请人：Bair Kenneth W.

  公开号：US09169209B2

  公开（公告）日：2015-10-27

  The present invention relates to compounds and composition for inhibition of NAMPT, their synthesis, applications and antidotes. An illustrative compound of the invention is shown below.

  本发明涉及用于抑制NAMPT的化合物和组合物，它们的合成、应用和解毒剂。本发明的一个示例化合物如下所示。